Market News How it works Learn FAQ
| TGL 0.2897 30.79% | SRTM 0.6164 43.25% | NU 11.845 -21.87% | GCDT 0.1604 -8.92% | EWZ 31.98 -24.91% | NWGL 0.0808 -1.46% | SHFS 0.1254 -5.29% | RBNE 0.183 -3.68% | CLRO 4.2705 31.40% | SPRC 1.635 50.00% | SOXL 87.29 4.46% | BBD 2.9088 -28.53% | VBIO 0.785 -16.49% | RENT 2.85 23.91% | ITUB 7.63 -21.10% | PBR 21.675 -17.14% | SOXS 50.2 -4.31% | TSLL 10.68 9.43% | SPCX 147.12 -0.25% | XP 14.42 -52.58% | XXII 0.1032 -47.80% | GPUS 0.1583 -6.28% | WFF 0.0741 -7.38% | KORU 10.59 0.09% | CRWV 52.0841 -3.97% | IREN 24.13 -3.11% | STNE 7.83 -31.79% | SQQQ 39.02 -1.66% | PRSO 0.35 -7.51% | NOK 8.44 3.69% | INTR 4.751 -33.92% | MYND 0.2219 -7.54% | TQQQ 67.37 1.63% | INTC 88.11 1.32% | VALE 12.27 -1.05% | NVDA 214.88 1.86% | TSLA 389.99 4.77% | VZ 43.45 -2.71% | IBIT 44.9769 -2.14% | WORX 2.2101 0.92% | YMAT 2.25 9.76% | AZTR 0.9102 1,173.01% | JBLU 2.4312 -7.38% | STLA 4.105 1.11% | WULF 11.36 0.35% | T 21.075 0.69% | IRE 2.9 -6.15% | PAGS 8.6 -24.83% | META 631.35 -1.75% | NBIS 151.07 -4.83%
VCVicore Pharma Holding AB logo

Vicore Pharma Holding AB (VCRE)

NASDAQ · Currency in USD
$9.34 ▼ -0.05 (-0.48%)
As of Oct 26, 10:07 AM ET. Market open.

Summary

Previous Close
$9.38
Open
$9.33
Day's Range
$9.32 – $9.34
52 Week Range
$7.88 – $17.80
Volume
357
Avg. Volume
27,701
Market Cap
$263.69M
Beta (5Y Monthly)
0.15
PE Ratio (TTM)
--
EPS (TTM)
-$17.83
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$25.00

Profile: Vicore Pharma Holding AB

Sector
Healthcare
Industry
Biotechnology
Full-time employees
37
CEO
Ahmed Mousa

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

Earnings

DateEst.Actual
Aug 21, 2026-$0.42-$0.51Miss
May 6, 2026-$0.05-$0.04Beat
Feb 27, 2026-$0.05-$0.06Miss
Nov 5, 2025-$0.05-$0.05Miss
Feb 27, 2025-$0.03-$0.05Miss
Nov 5, 2024–-$0.05

Analyst view

Consensus price target
$25.00 ▲ +167.8%
Range $25.00 – $25.00

Similar stocks

Get free alerts on VCRE and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.